Feb 2026 $3 M No. 5 $2 to $10 million 19
NexEos Diagnostics, Inc.: Raise no. 5, Feb 2026 × Investors in this round 19 investors had bought by the notice of Feb 17, 2026: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Stephen Tullman · Executive Officer, Director Theresa Mansi · Executive Officer Christopher Molineaux · Director Dennis Langer · Director Jeff Himawan · Director Louis Manzi · Director Nicholas Siciliano · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen Tullman, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 17, 2026. Read the notice at the SEC .
equity SEC May 2024 $5 M No. 4 $2 to $10 million 22
NexEos Diagnostics, Inc.: Raise no. 4, May 2024 × Investors in this round 22 investors had bought by the notice of Jun 6, 2024: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $10,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Stephen Tullman · Executive Officer, Director Christopher Molineaux · Director Dennis Langer · Director Jeff Himawan · Director Louis Manzi · Director Nicholas Siciliano · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen Tullman, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 6, 2024. Read the notice at the SEC .
equity SEC Feb 2023 $5 M No. 3 $2 to $10 million 19
NexEos Diagnostics, Inc.: Raise no. 3, Feb 2023 × Investors in this round 19 investors had bought by the notice of Feb 15, 2023: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $10,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $300,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Stephen Tullman · Executive Officer, Director Christopher Molineaux · Director Dennis Langer · Director Jeff Himawan · Director Louis Manzi · Director Nicholas Siciliano · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Stephen Tullman, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 15, 2023. Read the notice at the SEC .
equity SEC Oct 2021 $10 M No. 2 $2 to $10 million 21
NexEos Diagnostics, Inc.: Raise no. 2, Oct 2021 × Investors in this round 21 investors had bought by the notice of Oct 12, 2021: 21 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $10 M of $10 M offered
Smallest investment taken $20,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $300,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Theresa Mansi · Executive Officer, Director Christopher Molineaux · Director Dennis Langer · Director Jeffrey Himawan · Director Louis Manzi · Director Nicholas Sicilano · Director Stephen Tullman · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The foregoing amount includes $4,286,640 in the form of the cashless conversion of outstanding warrants.”On the use of proceeds: “Approximate amount expected to be used in the next 12 months in connection with the remuneration of executive officers.”Signed by Theresa Mansi, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 12, 2021. Read the notice at the SEC .
equity SEC Jul 2019 $3 M No. 1 $2 to $10 million 4
NexEos Diagnostics, Inc.: Raise no. 1, Jul 2019 × Investors in this round 4 investors had bought by the notice of Jul 30, 2019: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $6 M offered; $3 M still to sell
Smallest investment taken $20,000
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $400,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Stephen Tullman · Executive Officer, Director Theresa Mansi · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Theresa Mansi, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 30, 2019. Read the notice at the SEC .
equity, options SEC